|
YEATS2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.52744999999399E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.965080E-04 |
| Normal-vs-Stage2 |
4.362200E-04 |
| Normal-vs-Stage3 |
4.56490000000365E-06 |
| Normal-vs-Stage4 |
4.78979999996021E-06 |
| Stage1-vs-Stage2 |
5.456000E-01 |
| Stage1-vs-Stage3 |
1.356600E-01 |
| Stage1-vs-Stage4 |
1.353020E-01 |
| Stage2-vs-Stage3 |
6.470200E-01 |
| Stage2-vs-Stage4 |
4.825000E-01 |
| Stage3-vs-Stage4 |
7.508200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.15489999999541E-05 |
| Normal-vs-AfricanAmerican |
1.388810E-01 |
| Normal-vs-Asian |
1.74378999999725E-05 |
| Caucasian-vs-AfricanAmerican |
1.690820E-01 |
| Caucasian-vs-Asian |
4.107600E-01 |
| AfricanAmerican-vs-Asian |
6.588300E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.586830E-04 |
| Normal-vs-Female |
1.50786999999486E-05 |
| Male-vs-Female |
8.012200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.007800E-04 |
| Normal-vs-Age(41-60Yrs) |
1.64066999999157E-05 |
| Normal-vs-Age(61-80Yrs) |
9.59900000000458E-05 |
| Normal-vs-Age(81-100Yrs) |
3.439700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.532830E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.517600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.722400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.083600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.175200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.016600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.142200E-02 |
| Classical-VS-Follicular |
6.335600E-01 |
| Classical-VS-Other |
9.671200E-01 |
| Classical-VS-Normal |
7.61280000000086E-05 |
| Tall-VS-Follicular |
9.656200E-02 |
| Tall-VS-Other |
2.369600E-01 |
| Tall-VS-Normal |
1.40000000004026E-06 |
| Follicular-VS-Other |
8.537400E-01 |
| Follicular-VS-Normal |
3.004200E-04 |
| Other-VS-Normal |
9.826000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.97650000000249E-05 |
| Normal-vs-N1 |
1.88152999999192E-05 |
| N0-vs-N1 |
1.743420E-01 |
|
|
